查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1770846

ELISA 分析儀市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、按模式、按應用、按最終用戶、按地區和競爭進行細分，2020-2030 年預測

ELISA Analyzers Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Mode, By Application, By End user, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球 ELISA 分析儀市值為 6.1085 億美元，預計到 2030 年將達到 7.5924 億美元，複合年成長率為 3.65%。 ELISA（酵素連結免疫吸附試驗）分析儀是檢測和定量生物分子（包括抗體、抗原、蛋白質和荷爾蒙）的重要診斷儀器。這些系統擴大應用於免疫學、疫苗開發和藥物監測等一系列領域。全球慢性病和傳染病負擔日益加重，對準確、高通量診斷解決方案的需求不斷成長，使得 ELISA 分析儀成為現代醫療診斷的關鍵工具。隨著醫療保健系統優先考慮早期檢測、監測和標靶治療，ELISA 技術在診斷實驗室、製藥公司和研究機構中得到廣泛應用。自動化和檢測靈敏度的進步不斷提高 ELISA 分析儀的實用性和可擴展性，支持其在精準醫療和臨床診斷中的作用不斷擴大。

市場概覽
預測期 2026-2030
2024年市場規模 6.1085億美元
2030年市場規模 7.5924億美元
2025-2030 年複合年成長率 3.65%
成長最快的領域 自動化 ELISA 分析儀
最大的市場 北美洲

關鍵市場促進因素

慢性病和傳染病的盛行率不斷上升

主要市場挑戰

ELISA 分析儀和耗材成本高昂

主要市場趨勢

個人化和精準醫療需求不斷成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：ELISA 分析儀市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（濾光器ELISA 分析儀、光柵 ELISA 分析儀）
    • 按模式（自動 ELISA 分析儀、半自動分析儀）
    • 按應用（免疫學、疫苗開發、藥物監測、其他）
    • 按最終用戶（生物技術公司、製藥公司、合約研究組織、診斷實驗室）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美 ELISA 分析儀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲 ELISA 分析儀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太地區 ELISA 分析儀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美 ELISA 分析儀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲 ELISA 分析儀市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球 ELISA 分析儀市場：SWOT 分析

第 14 章：競爭格局

  • Thermo Fisher Scientific Inc.
  • Abcam Limited
  • Bio-Rad Laboratories, Inc.
  • Merck KgaA
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Trinity Biotech Plc.
  • Agilent Technologies, Inc.
  • QIAGEN
  • PerkinElmer US LLC.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 14956

The Global ELISA Analyzers Market was valued at USD 610.85 Million in 2024 and is projected to reach USD 759.24 Million by 2030, growing at a CAGR of 3.65%. ELISA (Enzyme-Linked Immunosorbent Assay) analyzers are essential diagnostic instruments used for detecting and quantifying biomolecules, including antibodies, antigens, proteins, and hormones. These systems are increasingly used across a range of applications such as immunology, vaccine development, and drug monitoring. The growing global burden of chronic and infectious diseases is fueling demand for accurate, high-throughput diagnostic solutions, making ELISA analyzers a critical tool in modern healthcare diagnostics. As healthcare systems prioritize early detection, monitoring, and targeted treatments, ELISA technologies are seeing widespread adoption across diagnostic laboratories, pharmaceutical companies, and research organizations. Advances in automation and assay sensitivity continue to enhance the utility and scalability of ELISA analyzers, supporting their expanding role in precision medicine and clinical diagnostics.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 610.85 Million
Market Size 2030USD 759.24 Million
CAGR 2025-20303.65%
Fastest Growing SegmentAutomated ELISA Analyzers
Largest MarketNorth America

Key Market Drivers

Growing Prevalence of Chronic and Infectious Diseases

The increasing incidence of chronic and infectious diseases is a primary force driving the global ELISA Analyzers Market. Noncommunicable diseases (NCDs) were responsible for approximately 43 million deaths in 2021, accounting for 75% of non-pandemic-related mortality. Notably, 18 million of these deaths occurred in individuals under age 70, with 82% concentrated in low- and middle-income countries (LMICs). Chronic conditions such as diabetes, cancer, cardiovascular disorders, and infectious diseases like HIV/AIDS, hepatitis, and emerging viruses-including COVID-19 and Zika-are placing unprecedented pressure on global health systems. ELISA analyzers, valued for their sensitivity, reliability, and high-throughput capabilities, are being increasingly deployed for disease diagnosis, monitoring, and research. Their ability to support early detection and manage complex disease profiles is especially critical in aging populations and resource-constrained regions, where effective diagnostic infrastructure is essential for reducing morbidity and mortality.

Key Market Challenges

High Costs of ELISA Analyzers and Consumables

A major constraint in the ELISA Analyzers Market is the high cost associated with acquiring and operating these systems. Advanced ELISA analyzers, particularly automated variants, can require investments ranging from tens of thousands to hundreds of thousands of dollars, making them inaccessible for many small to medium-sized laboratories, particularly in LMICs. The financial burden extends beyond equipment procurement to recurring costs for consumables such as reagents, kits, and regular maintenance. This ongoing expense poses a significant barrier to adoption, especially in facilities with limited budgets or operating in price-sensitive markets. These cost pressures often delay upgrades to newer systems or prevent adoption altogether, thereby limiting diagnostic capabilities and widening healthcare disparities between developed and developing regions.

Key Market Trends

Rising Demand for Personalized and Precision Medicine

The evolution of healthcare toward personalized and precision medicine is significantly influencing the ELISA Analyzers Market. Precision medicine focuses on tailoring treatment based on individual patient profiles, including genetic, molecular, and environmental factors. ELISA analyzers are playing a pivotal role in this shift due to their ability to detect and quantify disease-specific biomarkers, enabling clinicians to diagnose conditions more accurately and select targeted therapies. These systems are increasingly used in oncology, autoimmune disease management, and genetic testing to guide clinical decision-making. By integrating ELISA technology with genomic and proteomic data, healthcare providers can better predict disease risk and optimize treatment plans. The growing emphasis on early diagnosis, targeted therapies, and treatment monitoring is expected to further accelerate the demand for high-performance ELISA analyzers and advanced assay development.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Abcam Limited
  • Bio-Rad Laboratories, Inc.
  • Merck KgaA
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Trinity Biotech Plc.
  • Agilent Technologies, Inc.
  • QIAGEN
  • PerkinElmer U.S. LLC

Report Scope:

In this report, the Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Analyzers Market, By Product:

  • Optical Filter ELISA Analyzer
  • Optical Grating ELISA Analyzers

ELISA Analyzers Market, By Mode:

  • Automated ELISA Analyzers
  • Semi-Automated Analyzers

ELISA Analyzers Market, By Application:

  • Immunology
  • Vaccine Development
  • Drug Monitoring
  • Others

ELISA Analyzers Market, By End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organization
  • Diagnostic Laboratories

ELISA Analyzers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global ELISA Analyzers Market.

Available Customizations:

Global ELISA Analyzers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. ELISA Analyzers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Optical Filter ELISA Analyzer, Optical Grating ELISA Analyzers)
    • 5.2.2. By Mode (Automated ELISA Analyzers, Semi-Automated Analyzers)
    • 5.2.3. By Application (Immunology, Vaccine development, Drug Monitoring, Others)
    • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization, Diagnostic Laboratories)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America ELISA Analyzers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mode
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States ELISA Analyzers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Mode
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada ELISA Analyzers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Mode
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico ELISA Analyzers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Mode
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe ELISA Analyzers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mode
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany ELISA Analyzers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom ELISA Analyzers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy ELISA Analyzers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France ELISA Analyzers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Mode
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain ELISA Analyzers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Mode
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific ELISA Analyzers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mode
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China ELISA Analyzers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India ELISA Analyzers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan ELISA Analyzers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea ELISA Analyzers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia ELISA Analyzers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America ELISA Analyzers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mode
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil ELISA Analyzers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina ELISA Analyzers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia ELISA Analyzers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa ELISA Analyzers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Mode
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa ELISA Analyzers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia ELISA Analyzers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE ELISA Analyzers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global ELISA Analyzers Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Abcam Limited
  • 14.3. Bio-Rad Laboratories, Inc.
  • 14.4. Merck KgaA
  • 14.5. F. Hoffmann-La Roche Ltd
  • 14.6. Danaher Corporation
  • 14.7. Trinity Biotech Plc.
  • 14.8. Agilent Technologies, Inc.
  • 14.9. QIAGEN
  • 14.10.PerkinElmer U.S. LLC.

15. Strategic Recommendations

16. About Us & Disclaimer